In Q2 2026, LSI Alumni companies raised $1.9 billion, up from $1.2 billion in Q1, reflecting another active quarter for medtech funding.
The quarter included 47 funding events and strategic transactions, ranging from early-stage venture financings to late-stage growth rounds, acquisitions, IPOs, and strategic partnerships. Highlights included six acquisitions, two IPOs, and three $100 million financing rounds, reflecting continued investor interest in companies reaching key clinical, regulatory, and commercial milestones.
Investment activity spanned a wide range of sectors, including cardiovascular, neurotechnology, robotics, diagnostics, women’s health, and surgical innovation, offering a snapshot of where capital flowed across the medtech ecosystem during Q2.
The complete Q2 2026 LSI Alumni Funding Report includes every funding event and strategic transaction involving LSI Alumni companies during the quarter, including:
Whether you’re tracking emerging startups, monitoring investor activity, identifying acquisition trends, or following innovation across specific therapeutic areas, the report provides a comprehensive view of the companies shaping the future of medtech.
Join the LSI Mailing List
Upcoming Events
17011 Beach Blvd, Suite 500
Huntington Beach, CA 92647
© 2026 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy | Your Privacy Choices | Delete my Data